<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00239226</url>
  </required_header>
  <id_info>
    <org_study_id>EPASS</org_study_id>
    <nct_id>NCT00239226</nct_id>
  </id_info>
  <brief_title>Electrophysiologically Guided PAcing Site Selection Study</brief_title>
  <acronym>EPASS</acronym>
  <official_title>Investigational New Drug Application/ Investigational Device Exemption Information</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic BRC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic BRC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a long-term, prospective, and controlled evaluation of the incidence of
      persistent atrial fibrillation (AF) in patients with severe intra-right atrial conduction
      delay paced with preventive algorithms at the interatrial septum (IAS) versus right atrial
      appendage (RAA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The EPASS is a multicenter, prospective, randomized, and controlled study.

      Prior to entering the study, the patient should be informed and provide a written consent. In
      addition, the patient should meet all selection criteria. The Investigator has to check that
      all selection criteria are satisfied. Then the patient undergoes pacemaker implantation,
      receiving a pacemaker model T70 or Selection 9000 (or later version).

      Patients eligible for the study are enrolled and submitted to the evaluation of intra-light
      atrial conduction delay before device implantation. Besides, they are assigned to the group
      with severe RA conduction delay or with normal conduction delay. The randomization of the
      pacing site for both groups depends on the value of right atrial conduction delay, together
      with the associated diseases of the patients, sex and age. After implantation, a
      stabilization phase of 3-5 weeks is required to stabilize the leads: during this period the
      physician can optimize the device parameters. Neither the data regarding AF episodes nor
      cardioversion are collected.

      At the end of the stabilization phase the patient undergoes the 1st study follow-up and
      starts the monitoring period lasting 2 years. Regular follow-ups and data collection are
      scheduled every 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Persistent Atrial Fibrillation (AF) After a Mean Follow-up of 15±7 Months: Comparison Between IAS and RAA Pacing in the Study Group</measure>
    <time_frame>1 year</time_frame>
    <description>Persistent Atrial Fibrillation (AF) incidence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Persistent Atrial Fibrillation (AF) Episodes: Comparison Between All Groups</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Permanent Atrial Fibrillation (AF)</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom Scale Questionnaire: Comparison Between All Groups</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Cardioversion: Comparison Between All Groups</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Failure: Comparison Between All Groups</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Persistent Episode of Atrial Fibrillation (AF)</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Episodes/Day</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AF Burden</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular Pacing Percentage</measure>
    <time_frame>January 2009</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Sinus Arrhythmia</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>1. IAS pacing - study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients were first submitted to electrophysiological study to assess Delta CTos &gt; or &lt; 50 ms. Then they were randomized to interatrial septum pacing od right atrial appendage. This arm (1) includes patients with Delta CTos &gt;50 ms and randomized IAS pacing.
IAS Pacing -Study Group: Patients with Delta CTos &gt;50 ms (study group) at the electrophysiologic study and randomized Interatrial Septum Pacing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2. IAS pacing-control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(Delta CTos&lt;50ms)
Patients were first submitted to electrophysiological study to assess Delta CTos &gt; or &lt; 50 ms. Then they were randomized to interatrial septum pacing od right atrial appendage. This arm (2) includes patients with Delta CTos &lt;50 ms and randomized IAS pacing.
IAS Pacing -Control Group: Patients with Delta CTos &lt;50 ms (control group) at the electrophysiologic study and randomized Interatrial Septum Pacing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3. RAA Pacing - study group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients were first submitted to electrophysiological study to assess Delta CTos &gt; or &lt; 50 ms. Then they were randomized to interatrial septum pacing od right atrial appendage. This arm (3) includes patients with Delta CTos &gt;50 ms and randomized Right Atrial Appendage pacing.
RAA Pacing -Study Group: Patients with Delta CTos &gt;50 ms (study group) at the electrophysiologic study and randomized Right Atrial Appendage pacing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4. RAA Pacing - control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients were first submitted to electrophysiological study to assess Delta CTos &gt; or &lt; 50 ms. Then they were randomized to interatrial septum pacing od right atrial appendage. This arm (4) includes patients with Delta CTos &lt;50 ms and randomized Right Atrial Appendage pacing.
RAA Pacing -Control Group: Patients with Delta CTos &lt;50 ms (control group) at the electrophysiologic study and randomized Right Atrial Appendage pacing</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IAS pacing - study group</intervention_name>
    <description>site of implant and permanent pacing</description>
    <arm_group_label>1. IAS pacing - study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IAS pacing control group</intervention_name>
    <description>site of implant and permanent pacing</description>
    <arm_group_label>2. IAS pacing-control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pacing RAA study group</intervention_name>
    <description>site of implant and permanent pacing</description>
    <arm_group_label>3. RAA Pacing - study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pacing RAA control group</intervention_name>
    <description>site of implant and permanent pacing</description>
    <arm_group_label>4. RAA Pacing - control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic sinus node dysfunction

          -  More than 18 years old

          -  Signed informed consent

        Exclusion Criteria:

          -  Less than 18 years old

          -  Pregnancy

          -  Anamnestic transient ischemic attack (TIA) or stroke

          -  Neoplastic or any other severe disease reducing life expectancy

          -  Heart surgery in the last 3 months

          -  Left atrial diameter &gt; 55mm, determined in the parasternal long-axis view (during
             either sinus rhythm or atrial fibrillation)

          -  Participation in other studies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giorgio Corbucci, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medtronic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roberto Verlato, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Camposampiero Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Desenzano del Garda</name>
      <address>
        <city>Desenzano</city>
        <state>BS</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Divisione di Cardiologia</name>
      <address>
        <city>Como</city>
        <state>CO</state>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Divisione di Cardiologia - CRN</name>
      <address>
        <city>Pisa</city>
        <state>PI</state>
        <zip>56127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Divisione di Cardiologia - Ospedale Cisanello</name>
      <address>
        <city>Pisa</city>
        <state>PI</state>
        <zip>56127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Divisione di Cardiologia - Ospedale San Pietro Igneo</name>
      <address>
        <city>Fucecchio</city>
        <state>Prato</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Divisione di Cardiologia - Ospedale Molinette</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Divisione di Cardiologia - Ospedale Civile ULSS 13</name>
      <address>
        <city>Mirano</city>
        <state>VE</state>
        <zip>30035</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Divisione di Cardiologia - Presidi Ospedalieri Riuniti</name>
      <address>
        <city>Borgomanero</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Rosenqvist M, Brandt J, Schüller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J. 1988 Jul;116(1 Pt 1):16-22.</citation>
    <PMID>3394616</PMID>
  </reference>
  <reference>
    <citation>Stangl K, Seitz K, Wirtzfeld A, Alt E, Blömer H. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol. 1990 Dec;13(12 Pt 2):2080-5.</citation>
    <PMID>1704597</PMID>
  </reference>
  <reference>
    <citation>Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol. 1990 Mar 15;65(11):729-35.</citation>
    <PMID>2316455</PMID>
  </reference>
  <reference>
    <citation>Sgarbossa EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Castle LW, Trohman RG. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation. 1993 Sep;88(3):1045-53.</citation>
    <PMID>8353866</PMID>
  </reference>
  <reference>
    <citation>Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997 Oct 25;350(9086):1210-6.</citation>
    <PMID>9652562</PMID>
  </reference>
  <reference>
    <citation>Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000 May 11;342(19):1385-91.</citation>
    <PMID>10805823</PMID>
  </reference>
  <reference>
    <citation>Attuel P, Pellerin D, Mugica J, Coumel P. DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. Pacing Clin Electrophysiol. 1988 Nov;11(11 Pt 2):1647-54.</citation>
    <PMID>2463527</PMID>
  </reference>
  <reference>
    <citation>8. Daubert C, Mabo B, Berder V. Arrhythmia prevention by permanent atrial resynchronization in advanced interatrial block. Eur Heart J 1990;11: 237-42.</citation>
  </reference>
  <reference>
    <citation>Saksena S, Prakash A, Hill M, Krol RB, Munsif AN, Mathew PP, Mehra R. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol. 1996 Sep;28(3):687-94.</citation>
    <PMID>8772757</PMID>
  </reference>
  <reference>
    <citation>Delfaut P, Saksena S, Prakash A, Krol RB. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol. 1998 Dec;32(7):1900-8.</citation>
    <PMID>9857870</PMID>
  </reference>
  <reference>
    <citation>11. Prakash A, Giorgberidze I. Endocardial mapping of sites of conduction delay for atrial premature beats in patients with atrial fibrillation. PACE 1997;20 (part II):1161.</citation>
  </reference>
  <reference>
    <citation>Papageorgiou P, Monahan K, Boyle NG, Seifert MJ, Beswick P, Zebede J, Epstein LM, Josephson ME. Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation. Circulation. 1996 Aug 1;94(3):384-9.</citation>
    <PMID>8759080</PMID>
  </reference>
  <reference>
    <citation>Cosio FG, Palacios J, Vidal JM, Cocina EG, Gómez-Sánchez MA, Tamargo L. Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol. 1983 Jan 1;51(1):122-30.</citation>
    <PMID>6849250</PMID>
  </reference>
  <reference>
    <citation>Padeletti L, Porciani MC, Michelucci A, Colella A, Ticci P, Vena S, Costoli A, Ciapetti C, Pieragnoli P, Gensini GF. Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol. 1999 Mar;3(1):35-43.</citation>
    <PMID>10354974</PMID>
  </reference>
  <reference>
    <citation>Padeletti L, Pürerfellner H, Adler SW, Waller TJ, Harvey M, Horvitz L, Holbrook R, Kempen K, Mugglin A, Hettrick DA; Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol. 2003 Nov;14(11):1189-95.</citation>
    <PMID>14678133</PMID>
  </reference>
  <reference>
    <citation>Stabile G, Senatore G, De Simone A, Turco P, Coltorti F, Nocerino P, Vitale DF, Chiariello M. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences. J Cardiovasc Electrophysiol. 1999 Jan;10(1):2-9.</citation>
    <PMID>9930903</PMID>
  </reference>
  <reference>
    <citation>De Sisti A, Attuel P, Manot S, Fiorello P, Halimi F, Leclercq JF. Electrophysiological characteristics of the atrium in sinus node dysfunction with and without postpacing atrial fibrillation. Pacing Clin Electrophysiol. 2000 Mar;23(3):303-8.</citation>
    <PMID>10750128</PMID>
  </reference>
  <reference>
    <citation>Leclercq JF, De Sisti A, Fiorello P, Halimi F, Manot S, Attuel P. Is dual site better than single site atrial pacing in the prevention of atrial fibrillation? Pacing Clin Electrophysiol. 2000 Dec;23(12):2101-7.</citation>
    <PMID>11202254</PMID>
  </reference>
  <reference>
    <citation>19. Attuel P, Pellerin D, Gaston J et al: Latent atrial vulnerability: new means of electrophysiologic investigation in atrial arrhythmias. In Attuel P, Coumel P, Janse M,eds:The Atrium in Health and Disease.Futura Publishing Co.,Inc.,Mt.Kisco,NY,1989,pp159-200.</citation>
  </reference>
  <reference>
    <citation>Becker R, Klinkott R, Bauer A, Senges JC, Schreiner KD, Voss F, Kuebler W, Schoels W. Multisite pacing for prevention of atrial tachyarrhythmias: potential mechanisms. J Am Coll Cardiol. 2000 Jun;35(7):1939-46.</citation>
    <PMID>10841247</PMID>
  </reference>
  <reference>
    <citation>Duytschaever M, Danse P, Eysbouts S, Allessie M. Is there an optimal pacing site to prevent atrial fibrillation?: an experimental study in the chronically instrumented goat. J Cardiovasc Electrophysiol. 2002 Dec;13(12):1264-71.</citation>
    <PMID>12521344</PMID>
  </reference>
  <reference>
    <citation>Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol. 2001 Aug;12(8):912-7.</citation>
    <PMID>11513442</PMID>
  </reference>
  <reference>
    <citation>Hermida JS, Carpentier C, Kubala M, Otmani A, Delonca J, Jarry G, Rey JL. Atrial septal versus atrial appendage pacing: feasibility and effects on atrial conduction, interatrial synchronization, and atrioventricular sequence. Pacing Clin Electrophysiol. 2003 Jan;26(1 Pt 1):26-35.</citation>
    <PMID>12685136</PMID>
  </reference>
  <reference>
    <citation>Padeletti L, Michelucci A, Pieragnoli P, Colella A, Musilli N. Atrial septal pacing: a new approach to prevent atrial fibrillation. Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 2):850-4. Review.</citation>
    <PMID>15189515</PMID>
  </reference>
  <reference>
    <citation>Duytschaever M, Firsovaite V, Colpaert R, Allessie M, Tavernier R. Limited benefit of septal pre-excitation in pace prevention of atrial fibrillation. J Cardiovasc Electrophysiol. 2005 Mar;16(3):269-77.</citation>
    <PMID>15817085</PMID>
  </reference>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2005</study_first_submitted>
  <study_first_submitted_qc>October 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2005</study_first_posted>
  <results_first_submitted>November 6, 2009</results_first_submitted>
  <results_first_submitted_qc>September 20, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 25, 2013</results_first_posted>
  <last_update_submitted>September 20, 2013</last_update_submitted>
  <last_update_submitted_qc>September 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>interatrial septum</keyword>
  <keyword>atrial pacing</keyword>
  <keyword>symptomatic sinus node dysfunction,</keyword>
  <keyword>pacemaker indication class I</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Arrhythmia, Sinus</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment: november 2005 - may 2008 Sites:Ospedale P. Cosma Camposampiero-Ospedale Civile ULSS 13 Mirano-Ospdale Civile,Como-Ospedale Cisanello,Pisa-CRN,Pisa-Ospedale civile, Livorno-Ospedale Molinette, Torino-Presidi Ospedalieri Riuniti,Borgomanero-Ospedale San Pietro Igneo, Fucecchio-Azienda Ospedaliera di Desenzano del Garda Desenzano</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>IAS Pacing Study Group</title>
          <description>Patients with with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to interatrial septum (IAS) pacing.</description>
        </group>
        <group group_id="P2">
          <title>IAS Pacing Control Group</title>
          <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to interatrial septum (IAS) pacing.</description>
        </group>
        <group group_id="P3">
          <title>RAA Pacing Study Group</title>
          <description>Patients with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to right atrial appendage (RAA) pacing.</description>
        </group>
        <group group_id="P4">
          <title>RAA Pacing Control Group</title>
          <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to right atrial appendage (RAA) pacing.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="37"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="36"/>
                <participants group_id="P4" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>permAF during stabilization period</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IAS Pacing Study Group</title>
          <description>Patients with with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to interatrial septum (IAS) pacing.</description>
        </group>
        <group group_id="B2">
          <title>IAS Pacing Control Group</title>
          <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to interatrial septum (IAS) pacing.</description>
        </group>
        <group group_id="B3">
          <title>RAA Pacing Study Group</title>
          <description>Patients with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to right atrial appendage (RAA) pacing.</description>
        </group>
        <group group_id="B4">
          <title>RAA Pacing Control Group</title>
          <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to right atrial appendage (RAA) pacing.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="37"/>
            <count group_id="B4" value="17"/>
            <count group_id="B5" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75" spread="7"/>
                    <measurement group_id="B2" value="79" spread="6"/>
                    <measurement group_id="B3" value="75" spread="7"/>
                    <measurement group_id="B4" value="81" spread="5"/>
                    <measurement group_id="B5" value="77" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Persistent Atrial Fibrillation (AF) After a Mean Follow-up of 15±7 Months: Comparison Between IAS and RAA Pacing in the Study Group</title>
        <description>Persistent Atrial Fibrillation (AF) incidence</description>
        <time_frame>1 year</time_frame>
        <population>97 pts completed the study after a mean fu period of 15±7 months.</population>
        <group_list>
          <group group_id="O1">
            <title>IAS Pacing Study Group</title>
            <description>Patients with with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to interatrial septum (IAS) pacing.</description>
          </group>
          <group group_id="O2">
            <title>IAS Pacing Control Group</title>
            <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to interatrial septum (IAS) pacing.</description>
          </group>
          <group group_id="O3">
            <title>RAA Pacing Study Group</title>
            <description>Patients with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to right atrial appendage (RAA) pacing.</description>
          </group>
          <group group_id="O4">
            <title>RAA Pacing Control Group</title>
            <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to right atrial appendage (RAA) pacing.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Persistent Atrial Fibrillation (AF) After a Mean Follow-up of 15±7 Months: Comparison Between IAS and RAA Pacing in the Study Group</title>
          <description>Persistent Atrial Fibrillation (AF) incidence</description>
          <population>97 pts completed the study after a mean fu period of 15±7 months.</population>
          <units>Number of patients with persistent AF</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="36"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.047</p_value>
            <method>Log Rank</method>
            <param_type>Slope</param_type>
            <param_value>3.93</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Persistent Atrial Fibrillation (AF) Episodes: Comparison Between All Groups</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Permanent Atrial Fibrillation (AF)</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptom Scale Questionnaire: Comparison Between All Groups</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Cardioversion: Comparison Between All Groups</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Failure: Comparison Between All Groups</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Persistent Episode of Atrial Fibrillation (AF)</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Episodes/Day</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AF Burden</title>
        <time_frame>January 2009</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ventricular Pacing Percentage</title>
        <time_frame>January 2009</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>IAS Pacing Study Group</title>
          <description>Patients with with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to interatrial septum (IAS) pacing.</description>
        </group>
        <group group_id="E2">
          <title>IAS Pacing Control Group</title>
          <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to interatrial septum (IAS) pacing.</description>
        </group>
        <group group_id="E3">
          <title>RAA Pacing Study Group</title>
          <description>Patients with severe conduction delay (Delta CTos &gt;50 ms, Study Group) randomized to right atrial appendage (RAA) pacing.</description>
        </group>
        <group group_id="E4">
          <title>RAA Pacing Control Group</title>
          <description>Patients without severe conduction delay (Delta CTos &lt;50 ms, Control Group) randomized to right atrial appendage (RAA) pacing.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for HF</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>INVESTIGATOR may publish/present the results of the work. However, INVESTIGATOR shall provide copies of any abstracts, or manuscripts to the sponsor for review at least 30 (thirty) days prior to submittal for publication or presentation. The sponsor shall limit its review to a determination of whether Confidential Information is disclosed and to check for technical correctness. Sponsor shall not attempt to censor or in any way interfere with INVESTIGATOR’s presentation or conclusions.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Giorgio Corbucci - Sr Principal Scientist</name_or_title>
      <organization>Medtronic BRC - Medtronic Italia SpA</organization>
      <phone>+39 02 241371</phone>
      <email>giovanna.zucchi@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

